Skip to content
6-K

Foreign Interim / Material

AVRICORE HEALTH INC. AVCRF

0001493152-23-043903

← back to feed
Filed
Dec 6, 2023 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Diluted Q3 2023 · Sep 30, 2023 99.64M sh
Shares Diluted Q3 2023 · Sep 30, 2023 99.52M sh
Shares Diluted Q3 2023 · Sep 30, 2022 97.7M sh
Shares Diluted Q3 2023 · Sep 30, 2022 97.68M sh
Operating Cash Flow Q3 2023 · Sep 30, 2023 412.4K
Operating Cash Flow Q3 2023 · Sep 30, 2022 −413.56K
Cash And Equivalents Q3 2023 · Sep 30, 2023 389.53K
Cash And Equivalents Q3 2023 · Dec 31, 2022 620.53K
Cash And Equivalents Q3 2023 · Sep 30, 2022 869.13K
Cash And Equivalents Q3 2023 · Dec 31, 2021 2.01M
Stockholders Equity Q3 2023 · Sep 30, 2023 1.81M
Stockholders Equity Q3 2023 · Dec 31, 2022 1.96M
Stockholders Equity Q3 2023 · Sep 30, 2022 1.75M
Stockholders Equity Q3 2023 · Dec 31, 2021 2.2M
Current Liabilities Q3 2023 · Sep 30, 2023 646.5K
Current Liabilities Q3 2023 · Dec 31, 2022 604.89K
Current Assets Q3 2023 · Sep 30, 2023 916.98K
Current Assets Q3 2023 · Dec 31, 2022 1.43M
Total Assets Q3 2023 · Sep 30, 2023 2.45M
Total Assets Q3 2023 · Dec 31, 2022 2.57M
Eps Diluted Q3 2023 · Sep 30, 2023 0.00
Eps Diluted Q3 2023 · Sep 30, 2023 −0.01
Eps Diluted Q3 2023 · Sep 30, 2022 0.00
Eps Diluted Q3 2023 · Sep 30, 2022 0.00
Eps Basic Q3 2023 · Sep 30, 2023 0.00
Eps Basic Q3 2023 · Sep 30, 2023 −0.01
Eps Basic Q3 2023 · Sep 30, 2022 0.00
Eps Basic Q3 2023 · Sep 30, 2022 0.00
Gross Profit Q3 2023 · Sep 30, 2023 261.78K
Gross Profit Q3 2023 · Sep 30, 2023 701.93K
Gross Profit Q3 2023 · Sep 30, 2022 215.96K
Gross Profit Q3 2023 · Sep 30, 2022 287.95K
Cost Of Revenue Q3 2023 · Sep 30, 2023 691.68K
Cost Of Revenue Q3 2023 · Sep 30, 2023 1.43M
Cost Of Revenue Q3 2023 · Sep 30, 2022 356.27K
Cost Of Revenue Q3 2023 · Sep 30, 2022 503.19K
Revenue Q3 2023 · Sep 30, 2023 953.45K
Revenue Q3 2023 · Sep 30, 2023 2.13M
Revenue Q3 2023 · Sep 30, 2022 572.23K
Revenue Q3 2023 · Sep 30, 2022 791.14K